Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 13, 2021; 96 (15 Supplement) Saturday, April 17

The utility of the GAD-7 anxiety, NDDI-E depression, Epworth sleepiness and QOLIE-31-P quality of life scales in patients with epilepsy in real clinical practice (2379)

Alicia Gonzalez-Martinez, Álvaro Planchuelo-Gómez, Francisco Martínez-Dubarbie, Alba Vieira Campos, José Vivancos, María De Toledo
First published April 13, 2021,
Alicia Gonzalez-Martinez
1Neurology, Neurology Department, Hospital Universitario De La Princesa & Instituto de Investigación Sanitaria La Princesa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Álvaro Planchuelo-Gómez
2Neurology, Laboratorio de Procesado de Imagen (LPI), Universidad de Valladolid, Valladolid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Martínez-Dubarbie
3Neurology Department, Hospital de Laredo, Santander, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alba Vieira Campos
4Neurology, Epilepsy Unit, Neurology Department, Hospital Universitario De La Princesa & Instituto de Investigación Sanitaria La Princesa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Vivancos
1Neurology, Neurology Department, Hospital Universitario De La Princesa & Instituto de Investigación Sanitaria La Princesa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María De Toledo
4Neurology, Epilepsy Unit, Neurology Department, Hospital Universitario De La Princesa & Instituto de Investigación Sanitaria La Princesa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
The utility of the GAD-7 anxiety, NDDI-E depression, Epworth sleepiness and QOLIE-31-P quality of life scales in patients with epilepsy in real clinical practice (2379)
Alicia Gonzalez-Martinez, Álvaro Planchuelo-Gómez, Francisco Martínez-Dubarbie, Alba Vieira Campos, José Vivancos, María De Toledo
Neurology Apr 2021, 96 (15 Supplement) 2379;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: The objective of this project is to study the presence of psychiatric comorbidity (anxiety and depression), somnolence and quality of life using validated scales in patients with epilepsy in real clinical practice, and its relationship with other clinical and demographic variables.

Background: Previous studies have shown that psychiatric comorbidity, specially anxiety and depression, as well as sleep disorders are more prevalent in patients with epilepsy than in the general population.

Design/Methods: Cross-sectional descriptive observational study using validated scales of anxiety disorders(GAD-7), depression(NDDI-E), sleep disorders(Epworth) and quality of life(QOLIE-31-P) in patients with epilepsy treated in the Refractory Epilepsy Unit of a tertiary hospital.

Results: We recruited 84 patients, age 44.3 ± 17.4 years, 48.2% women, duration of epilepsy 21.5 ± 15.9 years, number of antiepileptic drugs 1.9 ± 1.2. We found severe anxiety(GAD-7> 14) in 14.3%, depression(NDDI-E> 15) in 20.2%; abnormal sleepiness(Epworth> 10) in 14.3% of patients, and QOLIE-31-P 62.0 ± 19.2. Each more point in GAD-7 is 21% more likely to suffer from anxiety(OR 1.21; 95% CI 1.09–1.36; p = 0.0008), NDDI-E scores≤15 represent 85 % less chance of having depression(OR 0.15; 95% CI 0.04–0.51]; p = 0.002). We found a positive association between depression according to NDDI-E with seizure frequency(p = 0.017) and number of drugs(p = 0.019); and severe anxiety according to GAD-7 and number of drugs(p = 0.019). We found a negative correlation between QOLIE-31-P with NDDI-E(r = −0.68; p <0.0001) and GAD-7(r = −0.76; p <0.0001).

Conclusions: Validated scales in epilepsy for the detection of anxiety(GAD-7) and depression(NDDI-E) are useful in the detection of these disorders in real clinical practice. The assessment of the presence of anxiety-depressive psychiatric comorbidity is especially relevant in patients with a higher frequency of seizures, a greater number of drugs and a poorer quality of life.

Disclosure: Alicia Gonzalez-Martinez, MD has nothing to disclose.Álvaro Planchuelo-Gómez has received research support from Junta de Castilla y León (Spain) & European Social Fund. Francisco Martínez Dubarbie has nothing to disclose. Vieira Campos Alba has nothing to disclose. Jose A. Vivancos Mora has nothing to disclose. Maria de Toledo Heras has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise